Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Vector Oncology
ClinicalTrials.gov Identifier:
NCT01330966
First received: April 6, 2011
Last updated: April 6, 2016
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)